Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXL-1020 in chronic heart failure
NCT01092325Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CXL-1020 in heart failure (HF), sponsored by Bristol Myers Squibb. Started Jun 2009; status: completed.
02
Drugs
CXL-1020
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01092325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092325.